ID   MP2K7_HUMAN             Reviewed;         419 AA.
AC   O14733; B2R9S5; O14648; O14816; O60452; O60453; Q1PG43; Q8IY10;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   02-NOV-2010, entry version 103.
DE   RecName: Full=Dual specificity mitogen-activated protein kinase kinase 7;
DE            Short=MAP kinase kinase 7;
DE            Short=MAPKK 7;
DE            EC=2.7.12.2;
DE   AltName: Full=JNK-activating kinase 2;
DE   AltName: Full=MAPK/ERK kinase 7;
DE            Short=MEK 7;
DE   AltName: Full=c-Jun N-terminal kinase kinase 2;
DE            Short=JNK kinase 2;
DE            Short=JNKK 2;
GN   Name=MAP2K7; Synonyms=JNKK2, MEK7, MKK7, PRKMK7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Heart, and Skeletal muscle;
RX   MEDLINE=98038808; PubMed=9372971;
RA   Wu Z., Wu J., Jacinto E., Karin M.;
RT   "Molecular cloning and characterization of human JNKK2, a novel jun
RT   NH2-terminal kinase-specific kinase.";
RL   Mol. Cell. Biol. 17:7407-7416(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND ENZYME
RP   REGULATION.
RX   MEDLINE=97460048; PubMed=9312068; DOI=10.1074/jbc.272.40.24751;
RA   Lu X., Nemoto S., Lin A.;
RT   "Identification of c-Jun NH2-terminal protein kinase (JNK)-activating
RT   kinase 2 as an activator of JNK but not p38.";
RL   J. Biol. Chem. 272:24751-24754(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TISSUE
RP   SPECIFICITY, AND VARIANT PHE-259.
RC   TISSUE=Fetal kidney;
RX   MEDLINE=98204938; PubMed=9535930; DOI=10.1074/jbc.273.15.9344;
RA   Foltz I.N., Gerl R.E., Wieler J.S., Luckach M., Salmon R.A.,
RA   Schrader J.W.;
RT   "Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly
RT   conserved c-Jun N-terminal kinase/stress-activated protein kinase
RT   (JNK/SAPK) activated by environmental stresses and physiological
RT   stimuli.";
RL   J. Biol. Chem. 273:9344-9351(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), ENZYME REGULATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16442502; DOI=10.1016/j.bbrc.2005.12.223;
RA   Michael L., Swantek J., Robinson M.J.;
RT   "Cloning and expression of human mitogen-activated protein kinase
RT   kinase 7gamma1.";
RL   Biochem. Biophys. Res. Commun. 341:679-683(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Yang J., New L., Yong J., Han J., Su B.;
RT   "Molecular cloning of human JNKK2 reveals a novel kinase module for c-
RT   Jun N-terminal kinase activation.";
RL   Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-260 (ISOFORMS 1/4).
RX   MEDLINE=97352799; PubMed=9207092; DOI=10.1073/pnas.94.14.7337;
RA   Tournier C., Whitmarsh A.J., Cavanagh J., Barrett T., Davis R.J.;
RT   "Mitogen-activated protein kinase kinase 7 is an activator of the c-
RT   Jun NH2-terminal kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:7337-7342(1997).
RN   [10]
RP   CLEAVAGE BY ANTHRAX LETHAL FACTOR.
RX   MEDLINE=20558083; PubMed=11104681; DOI=10.1042/0264-6021:3520739;
RA   Vitale G., Bernardi L., Napolitani G., Mock M., Montecucco C.;
RT   "Susceptibility of mitogen-activated protein kinase kinase family
RT   members to proteolysis by anthrax lethal factor.";
RL   Biochem. J. 352:739-745(2000).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-118; CYS-138; CYS-162; HIS-162 AND
RP   THR-195.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Stress activated, dual specificity kinase that activates
CC       the JUN kinases MAPK8/JNK1, MAPK9/JNK2 and MAPK10/JNK3.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by phosphorylation by specific MAP
CC       kinase kinase kinases such as MAP3K1/MEKK1, MAP3K3/MEKK3,
CC       MAP3K11/MLK3 and MAP3K12/DLK.
CC   -!- INTERACTION:
CC       P45983:MAPK8; NbExp=2; IntAct=EBI-492605, EBI-286483;
CC       Q96RU7:TRIB3; NbExp=1; IntAct=EBI-492605, EBI-492476;
CC       Q86Y07:VRK2; NbExp=1; IntAct=EBI-492605, EBI-1207615;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=A;
CC         IsoId=O14733-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=O14733-2; Sequence=VSP_004883;
CC       Name=3; Synonyms=gamma1;
CC         IsoId=O14733-3; Sequence=VSP_022309;
CC       Name=4;
CC         IsoId=O14733-4; Sequence=VSP_022310;
CC         Note=No experimental confirmation available;
CC   -!- TISSUE SPECIFICITY: Ubiquitous; with highest level of expression
CC       in skeletal muscle. Isoform 3 is found at low levels in placenta,
CC       fetal liver, and skeletal muscle.
CC   -!- PTM: Activated by phosphorylation on Ser/Thr.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF014401; AAB88048.1; -; mRNA.
DR   EMBL; AF006689; AAB97813.1; ALT_TERM; mRNA.
DR   EMBL; AF013588; AAC16272.1; -; mRNA.
DR   EMBL; AF013589; AAC16273.1; -; mRNA.
DR   EMBL; DQ445915; ABE03013.1; -; mRNA.
DR   EMBL; AF022805; AAC26142.1; -; mRNA.
DR   EMBL; AK313899; BAG36622.1; -; mRNA.
DR   EMBL; CH471139; EAW68964.1; -; Genomic_DNA.
DR   EMBL; BC038295; AAH38295.1; -; mRNA.
DR   EMBL; AF003199; AAB63374.1; -; mRNA.
DR   IPI; IPI00023636; -.
DR   IPI; IPI00302112; -.
DR   IPI; IPI00745806; -.
DR   IPI; IPI00794495; -.
DR   RefSeq; NP_660186.1; -.
DR   UniGene; Hs.531754; -.
DR   PDB; 2DYL; X-ray; 2.45 A; A=101-405.
DR   PDBsum; 2DYL; -.
DR   ProteinModelPortal; O14733; -.
DR   IntAct; O14733; 21.
DR   MINT; MINT-1378223; -.
DR   STRING; O14733; -.
DR   PhosphoSite; O14733; -.
DR   PRIDE; O14733; -.
DR   Ensembl; ENST00000397979; ENSP00000381066; ENSG00000076984.
DR   GeneID; 5609; -.
DR   KEGG; hsa:5609; -.
DR   UCSC; uc002mit.1; human.
DR   UCSC; uc002miu.1; human.
DR   UCSC; uc002miv.1; human.
DR   CTD; 5609; -.
DR   GeneCards; GC19P007968; -.
DR   H-InvDB; HIX0202887; -.
DR   HGNC; HGNC:6847; MAP2K7.
DR   HPA; CAB004262; -.
DR   HPA; HPA001633; -.
DR   MIM; 603014; gene.
DR   PharmGKB; PA284; -.
DR   HOVERGEN; HBG108518; -.
DR   OrthoDB; EOG9CRPJQ; -.
DR   PhylomeDB; O14733; -.
DR   BRENDA; 2.7.12.2; 247.
DR   Pathway_Interaction_DB; anthraxpathway; Cellular roles of Anthrax toxin.
DR   Pathway_Interaction_DB; fcer1pathway; Fc-epsilon receptor I signaling in mast cells.
DR   Pathway_Interaction_DB; hivnefpathway; HIV-1 Nef: Negative effector of Fas and TNF-alpha.
DR   Pathway_Interaction_DB; reelinpathway; Reelin signaling pathway.
DR   Pathway_Interaction_DB; tnfpathway; TNF receptor signaling pathway.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   DrugBank; DB00773; Etoposide.
DR   NextBio; 21802; -.
DR   PMAP-CutDB; O14733; -.
DR   ArrayExpress; O14733; -.
DR   Bgee; O14733; -.
DR   CleanEx; HS_MAP2K7; -.
DR   Genevestigator; O14733; -.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004708; F:MAP kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0051403; P:stress-activated MAPK cascade; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Coiled coil; Complete proteome; Cytoplasm; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Serine/threonine-protein kinase; Transferase;
KW   Tyrosine-protein kinase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    419       Dual specificity mitogen-activated
FT                                protein kinase kinase 7.
FT                                /FTId=PRO_0000086388.
FT   DOMAIN      120    380       Protein kinase.
FT   NP_BIND     126    134       ATP (By similarity).
FT   COILED        2     30       Potential.
FT   ACT_SITE    243    243       Proton acceptor (By similarity).
FT   BINDING     149    149       ATP (By similarity).
FT   SITE         44     45       Cleavage; by anthrax lethal factor.
FT   SITE         76     77       Cleavage; by anthrax lethal factor.
FT   MOD_RES       2      2       N-acetylalanine.
FT   VAR_SEQ      42     42       T -> IIVITLSPAPAPSQRAA (in isoform 3).
FT                                /FTId=VSP_022309.
FT   VAR_SEQ     111    111       Q -> QVPPSLWRGEGGGPARLDPSWERQWGAGGGGRAPGT
FT                                LQPSLSSQ (in isoform 2).
FT                                /FTId=VSP_004883.
FT   VAR_SEQ     312    312       L -> LPCPSPSQ (in isoform 4).
FT                                /FTId=VSP_022310.
FT   VARIANT     118    118       N -> S (in dbSNP:rs56316660).
FT                                /FTId=VAR_040825.
FT   VARIANT     138    138       R -> C (in dbSNP:rs56106612).
FT                                /FTId=VAR_040826.
FT   VARIANT     162    162       R -> C (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040827.
FT   VARIANT     162    162       R -> H (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040828.
FT   VARIANT     195    195       A -> T (in dbSNP:rs55800262).
FT                                /FTId=VAR_040829.
FT   VARIANT     259    259       L -> F (in dbSNP:rs1053566).
FT                                /FTId=VAR_029890.
FT   CONFLICT     94     94       Q -> H (in Ref. 2; AAB97813).
FT   CONFLICT    106    106       L -> P (in Ref. 4; ABE03013).
FT   CONFLICT    133    133       Q -> P (in Ref. 2; AAB97813).
FT   CONFLICT    142    142       T -> N (in Ref. 1; AAB88048).
FT   STRAND      105    114
FT   HELIX       117    119
FT   STRAND      120    125
FT   STRAND      134    139
FT   TURN        140    142
FT   STRAND      145    152
FT   HELIX       157    172
FT   TURN        173    175
FT   STRAND      182    187
FT   STRAND      189    196
FT   STRAND      200    202
FT   HELIX       203    210
FT   HELIX       216    237
FT   HELIX       246    248
FT   STRAND      249    251
FT   STRAND      257    259
FT   HELIX       286    289
FT   HELIX       302    317
FT   TURN        321    324
FT   HELIX       328    337
FT   STRAND      345    347
FT   HELIX       351    360
FT   TURN        365    367
FT   HELIX       371    374
FT   HELIX       378    385
FT   HELIX       390    399
SQ   SEQUENCE   419 AA;  47485 MW;  F1B22E050F54299A CRC64;
     MAASSLEQKL SRLEAKLKQE NREARRRIDL NLDISPQRPR PTLQLPLAND GGSRSPSSES
     SPQHPTPPAR PRHMLGLPST LFTPRSMESI EIDQKLQEIM KQTGYLTIGG QRYQAEINDL
     ENLGEMGSGT CGQVWKMRFR KTGHVIAVKQ MRRSGNKEEN KRILMDLDVV LKSHDCPYIV
     QCFGTFITNT DVFIAMELMG TCAEKLKKRM QGPIPERILG KMTVAIVKAL YYLKEKHGVI
     HRDVKPSNIL LDERGQIKLC DFGISGRLVD SKAKTRSAGC AAYMAPERID PPDPTKPDYD
     IRADVWSLGI SLVELATGQF PYKNCKTDFE VLTKVLQEEP PLLPGHMGFS GDFQSFVKDC
     LTKDHRKRPK YNKLLEHSFI KRYETLEVDV ASWFKDVMAK TESPRTSGVL SQPHLPFFR
//
